{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:35:05Z","timestamp":1787960105667,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/inf.0000000000000307","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T15:36:34Z","timestamp":1395243394000},"page":"837-842","source":"Crossref","is-referenced-by-count":20,"title":["Ceftaroline Activity Tested Against Bacterial Isolates From Pediatric Patients"],"prefix":"10.1097","volume":"33","author":[{"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.spid.2004.01.003","article-title":"Antimicrobial resistance among pediatric respiratory tract infections: clinical challenges.","volume":"15","author":"Jacobs","year":"2004","journal-title":"Semin Pediatr Infect Dis"},{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1097\/INF.0b013e318286c612","article-title":"ARPEC Project Group Members. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide.","volume":"32","author":"Versporten","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/eri.09.127","article-title":"Diagnosis and management of community-associated MRSA infections in children.","volume":"8","author":"Long","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.spid.2006.06.004","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus infections in children.","volume":"17","author":"Kaplan","year":"2006","journal-title":"Semin Pediatr Infect Dis"},{"issue":"Suppl 3","key":"R5-15-20210202","first-page":"iii45","article-title":"Review of ceftaroline fosamil microbiology: integrated FOCUS studies.","volume":"66","author":"Critchley","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-013-0075-6","article-title":"Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.","volume":"73","author":"Frampton","year":"2013","journal-title":"Drugs"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2165\/11635660-000000000-00000","article-title":"Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.","volume":"72","author":"Lodise","year":"2012","journal-title":"Drugs"},{"issue":"Suppl 3","key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1093\/cid\/cis563","article-title":"In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE surveillance program (2008-2010).","volume":"55","author":"Farrell","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/JCM.06384-11","article-title":"Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy.","volume":"50","author":"Leung","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates.","volume":"44","author":"Pai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cir625","article-title":"Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.","volume":"23","author":"David","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R17-15-20210202","first-page":"64","article-title":"Community-associated MRSA in the pediatric primary care setting.","volume":"34","author":"Hinckley","year":"2008","journal-title":"Pediatr Nurs"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/dkp241","article-title":"Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology.","volume":"64","author":"Tenover","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.279.8.593","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.","volume":"279","author":"Herold","year":"1998","journal-title":"JAMA"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-148-4-200802190-00204","article-title":"Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.","volume":"148","author":"Diep","year":"2008","journal-title":"Ann Intern Med"},{"key":"R21-15-20210202","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1469-0691.2009.02739.x","article-title":"Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.","volume":"15","author":"Leclercq","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/cid\/cis560","article-title":"Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.","volume":"55","author":"Sader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.01797-09","article-title":"Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.","volume":"54","author":"Jacobs","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2010.04.013","article-title":"Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.","volume":"36","author":"Jones","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2012.08.024","article-title":"Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).","volume":"75","author":"Jones","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/AAC.02252-12","article-title":"Prevalence of -lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).","volume":"57","author":"Castanheira","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.00330-12","article-title":"Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program.","volume":"56","author":"Flamm","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:03:19Z","timestamp":1620954199000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201408000-00015"}},"subtitle":["Results from the Assessing Worldwide Antimicrobial Resistance and Evaluation Program for the United States (2011\u20132012)"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000307","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}